Year archive

Neural Therapeutics Inc. — 2023 filings

All 20 regulatory filings released by Neural Therapeutics Inc. (NURL) in 2023, sourced directly from the official regulator.

20 Filings

2023 Period

2023 filings (20)

Filing	Released	Lang
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2023-11-24	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2023-11-24	English
AB form 13-501F2 (class 2 reporting issuers - participation fee).PDF Regulatory Filings	2023-11-24	English
Annual MD&A - English.pdf Regulatory Filings	2023-11-24	English
Audited annual financial statements – English.pdf Audit Report / Information	2023-11-24	English
News release - English.pdf Regulatory Filings	2023-07-27	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2023-06-29	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2023-06-29	English
Interim MD&A - English.pdf Interim / Quarterly Report	2023-06-29	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2023-06-29	English
News release - English.pdf Capital/Financing Update	2023-06-20	English
Other.pdf Capital/Financing Update	2023-06-13	English
Other.pdf Capital/Financing Update	2023-06-13	English
Other.pdf Capital/Financing Update	2023-06-13	English
Other.pdf Capital/Financing Update	2023-06-13	English
Other.pdf Capital/Financing Update	2023-06-13	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2023-06-01	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2023-06-01	English
Interim MD&A - English.pdf Interim / Quarterly Report	2023-06-01	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2023-06-01	English